Kynam Capital Management, LP Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$1.6B

Holdings

36

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (36 positions)

#StockSharesValue% PortfolioType
1
COGTCOGENT BIOSCIENCES INC
6,165,223$219.0M13.99%
2
VERAVERA THERAPEUTICS INC
3,433,051$173.8M11.11%
3
SNDXSYNDAX PHARMACEUTICALS INC
8,050,959$169.2M10.81%
4
TCE2CELLDEX THERAPEUTICS INC NEW
5,943,180$161.4M10.31%
5
PCVXVAXCYTE INC
2,922,335$134.8M8.61%
6
BEAMBEAM THERAPEUTICS INC
3,377,214$93.6M5.98%Call
7
BCRXBIOCRYST PHARMACEUTICALS INC
9,366,526$73.1M4.67%
8
VRDNVIRIDIAN THERAPEUTICS INC
1,470,541$45.8M2.92%
9
TYRATYRA BIOSCIENCES INC
1,564,492$41.1M2.63%
10
CGONCG ONCOLOGY INC
945,830$39.3M2.51%
11
CTMXCYTOMX THERAPEUTICS INC
8,966,077$38.2M2.44%
12
NRIXNURIX THERAPEUTICS INC
1,970,357$37.4M2.39%
13
WVEWAVE LIFE SCIENCES LTD
2,169,105$36.9M2.36%
14
CGEMCULLINAN THERAPEUTICS INC
3,114,132$32.2M2.06%
15
IMCRIMMUNOCORE HLDGS PLC
856,462$29.7M1.90%
16
MBXMBX BIOSCIENCES INC
934,799$29.5M1.88%
17
KALVKALVISTA PHARMACEUTICALS INC
1,810,954$29.2M1.87%
18
APLSAPELLIS PHARMACEUTICALS INC
908,607$22.8M1.46%
19
DVAXDYNAVAX TECHNOLOGIES CORP
1,375,632$21.2M1.35%
20
BNRBURNING ROCK BIOTECH LTD
994,883$20.0M1.28%
21
TVTXTRAVERE THERAPEUTICS INC
517,884$19.8M1.26%
22
PHVSPHARVARIS N V
640,395$17.8M1.14%
23
ENGNENGENE HOLDINGS INC
1,492,898$13.5M0.86%
24
RLAYRELAY THERAPEUTICS INC
1,424,259$12.0M0.77%
25
BHVNBIOHAVEN LTD
702,884$7.9M0.51%
26
DSGNDESIGN THERAPEUTICS INC
784,606$7.4M0.47%
27
STROSUTRO BIOPHARMA INC
479,590$5.5M0.35%
28
EH3AMARIN CORP PLC
389,273$5.4M0.35%
29
GONGERON CORP
3,456,318$4.6M0.29%
30
CLYMCLIMB BIO INC
1,028,341$4.1M0.26%
31
CRBUCARIBOU BIOSCIENCES INC
2,503,302$4.0M0.25%
32
OMEROMEROS CORP
200,000$3.4M0.22%Put
33
EVMNEVOMMUNE INC
185,482$3.2M0.20%
34
PRQRPROQR THRAPEUTICS N V
1,566,317$3.2M0.20%
35
ALECALECTOR INC
2,000,000$3.1M0.20%
36
PRLDPRELUDE THERAPEUTICS INC
788,867$2.3M0.15%